HALO logo
halo search icon
278650
HLB bioStep Co.Ltd.

278650 · HLB bioStep Co.Ltd.

3735.00

KRW
0.00 (0.00%)
07/10/2026 12:00:00 AM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

KRW84.63B

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 07/10/2026 12:00:00 AM

Price Chart

Description

HLB bioStep Co., Ltd. engages in the provision of clinical research services. It operates through the following business divisions: Non-Clinical Contract Research Organizations (CRO), Bioinfrastructure, and Pet Medical. The Non-Clinical CRO business division focuses on pharmacology and toxicity evaluation. The Bioinfrastructure business division is invloved in the design, construction, and maintenance of animal testing facilities, as well as supply of equipment and materials. The Pet Medical business division distributes and sells veterinary medicines. The company was founded on April 19, 2012 and is headquartered in Inchon, South Korea.

  • All-Companies
  • Big Candle
  • HALO All
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

1457.80%

EBITDA Margin

-5.30%

Operating Cashflow

₩3,086m

Free Cash Flow Return

2.90%

ROIC

-17.90%

Interest Coverage

-1.90

Quick Ratio

1.20

Performance

52 weeks range

Low 1500 - 10100

Trade Value (12mth)

US$158,150.00

1 week

14.92%

1 month

54.34%

YTD

-50.17%

1 year

-41.96%

All time high

219750.00

Additional Data

Shares Outstanding (Fully Diluted)

17m

HALO Sector

Industrials

Next Company Report Date

24-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

KRW

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
HLB Co., Ltd.Public Company
HLB Therapeutics Co., Ltd.Public Company
Yang-Gon JinIndividual
Myung-Jin KimIndividual
Soon-suk HwangIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of HLB bioStep Co.Ltd. (278650:KRX)?
Halo FAQ
The current share price of HLB bioStep Co.Ltd. (278650:KRX) is KRW₩3735.00.
2
What is the 52-week high share price for HLB bioStep Co.Ltd. (278650:KRX)?
Halo FAQ
The 52-week high share price for HLB bioStep Co.Ltd. (278650:KRX) is KRW₩10100.00.
3
What is the 52-week low share price for HLB bioStep Co.Ltd. (278650:KRX)?
Halo FAQ
The 52-week low share price for HLB bioStep Co.Ltd. (278650:KRX) is KRW₩1500.00.
4
What is the dividend yield for HLB bioStep Co.Ltd. (278650:KRX)?
Halo FAQ
HLB bioStep Co.Ltd. (278650:KRX) does not pay a dividend.
5
What was HLB bioStep Co.Ltd. (278650:KRX) last dividend payment?
Halo FAQ
The last dividend payment of HLB bioStep Co.Ltd. (278650:KRX) is KRW₩2.00.
6
What is the franking level for HLB bioStep Co.Ltd. (278650:KRX)?
Halo FAQ
HLB bioStep Co.Ltd. (278650:KRX) has a franking level of 0.00%.
7
In which sector is HLB bioStep Co.Ltd. (278650:KRX) classified?
Halo FAQ
HLB bioStep Co.Ltd. (278650:KRX) is classified in the Industrials.